BRIEF-Briacell Announces Positive Recommendation From Data Safety Monitoring Board For Pivotal Phase 3 Study In Metastatic Breast Cancer
Reuters
Jun 24
BRIEF-Briacell Announces Positive Recommendation From Data Safety Monitoring Board For Pivotal Phase 3 Study In Metastatic Breast Cancer
June 24 (Reuters) - Briacell Therapeutics Corp BCT.TO:
BRIACELL ANNOUNCES POSITIVE RECOMMENDATION FROM DATA SAFETY MONITORING BOARD FOR PIVOTAL PHASE 3 STUDY IN METASTATIC BREAST CANCER
BRIACELL THERAPEUTICS CORP - DSMB IDENTIFIES NO SAFETY CONCERNS, RECOMMENDS CONTINUATION OF BRIA-IMT PHASE 3 STUDY
Source text: ID:nGNX8D26wn
Further company coverage: BCT.TO
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.